24 May 2013
Keywords: s-p, compare, hep, therapies, schering-plough, corp, conduct
Article | 06 October 2003
Schering-Plough Corp is to conduct the first direct study to compare two approved forms of pegylated interferon therapy for chronic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 October 2003
23 May 2013
© 2013 thepharmaletter.com